Expert Opinion on Emerging Drugs, volume 29, issue 4, pages 321-325

ONC201 (Dordaviprone): review of evidence to date in diffuse midline glioma, hope or hype?

Jordan R. Hansford 1, 2, 3
Neevika Manoharan 4, 5, 6
G. Bouche 7
Vijay Ramaswamy 8, 9, 10
Nada Jabado 11
Publication typeJournal Article
Publication date2024-10-01
scimago Q1
wos Q2
SJR0.881
CiteScore5.9
Impact factor2.7
ISSN14728214, 17447623
Found 

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Share
Cite this
GOST | RIS | BibTex | MLA
Found error?
Profiles